Atlas FDA

Exablate Model 4000 Type 1.0 & Type 1.1 System (“Exablate Neuro”)

FDA premarket approval P150038/S033 · decided 2024-01-21

Approval details

PMA number
P150038
Supplement
S033
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Exablate Model 4000 Type 1.0 & Type 1.1 System (“Exablate Neuro”)
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2023-11-22
Decision date
2024-01-21
Days to decision
60 days
Decision code
APPR
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
approval for a manufacturing site located at R.H. Electronics Ltd., 5 Hatzoref St. Har-Yona Industrial Area, Nof Hagalil, Nazereth Illit, 17000, Israel, for assembly activities of the Exablate Neuro treatment kits

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.